This protocol is judged by an institutional evaluate board, an unbiased group that reviews any clinical trials involving human beings. If a review includes a Timetable I drug, as soon as the board approves the protocol as ethical, the researchers must apply for an investigational new drug (IND) quantity with the FDA.This post includes a list of sup